FLGC Stock Overview
Engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Flora Growth Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.13 |
| 52 Week High | US$2.93 |
| 52 Week Low | US$0.70 |
| Beta | 1.86 |
| 11 Month Change | -38.92% |
| 3 Month Change | 22.84% |
| 1 Year Change | 11.88% |
| 33 Year Change | -98.67% |
| 5 Year Change | n/a |
| Change since IPO | -98.82% |
Recent News & Updates
The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More
Sep 18
Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts
Aug 16Recent updates
The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More
Sep 18Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts
Aug 16Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch
May 22Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story
Apr 04Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%
Feb 17The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More
Dec 22Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding
Apr 17News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts
Dec 08Flora Growth gains on deal to acquire No Cap Hemp assets
Sep 07Elshad Garayev is the new finance chief of Flora Growth
Jul 11Shareholder Returns
| FLGC | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -13.1% | 2.7% | 1.0% |
| 1Y | 11.9% | -15.4% | 33.1% |
Return vs Industry: FLGC exceeded the US Personal Products industry which returned -13.1% over the past year.
Return vs Market: FLGC underperformed the US Market which returned 33.2% over the past year.
Price Volatility
| FLGC volatility | |
|---|---|
| FLGC Average Weekly Movement | 17.6% |
| Personal Products Industry Average Movement | 8.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FLGC's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: FLGC's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 103 | Clifford Starke | www.floragrowth.com |
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
Flora Growth Corp. Fundamentals Summary
| FLGC fundamental statistics | |
|---|---|
| Market cap | US$15.74m |
| Earnings (TTM) | -US$13.48m |
| Revenue (TTM) | US$69.01m |
0.2x
P/S Ratio-1.1x
P/E RatioIs FLGC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FLGC income statement (TTM) | |
|---|---|
| Revenue | US$69.01m |
| Cost of Revenue | US$53.55m |
| Gross Profit | US$15.45m |
| Other Expenses | US$28.93m |
| Earnings | -US$13.48m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.01 |
| Gross Margin | 22.39% |
| Net Profit Margin | -19.53% |
| Debt/Equity Ratio | 29.2% |
How did FLGC perform over the long term?
See historical performance and comparison